Tuesday, 31 July 2018

North America is the Largest Neurostimulation Device Market as the Region

Neurostimulation is the technology to delivery low voltage electricity to a specific nerve or target in the spinal cord or brain to affect neuronal transmission. It is a therapeutic tool used to treat neuropathic pain or to modulate motor function and for a range of different diseases such as epilepsy, migraine, and Parkinson’s disease. The global neurostimulation device market is growing at significant rate due to increasing prevalence of neurological diseases and growing geriatric population. The market has witnessed high demand for internal neurostimulation over the last few years, due to the increasing prevalence of neurological disorders.

The growing prevalence of neurological disorders, increasing prevalence of lifestyle associated diseases, robust product pipeline and mounting geriatric population are the primary growth drivers for neurostimulation device market. Neuromodulation devices have shown to be very effective in treating Parkinson’s and other chronic illnesses induced by old age. According to the WHO, globally depression is a common mental disorder and approximately 300 million people of all age group suffer from depression. Expanded target applications and new indications, increasing healthcare expenditure, increasing demand for minimally invasive surgeries, and increasing adoption of technological advanced products are also fueling the growth of the neurostimulation device market.

The lack of trained professionals and unfavorable reimbursement scenario are the major challenges for the growth of neurostimulation device market. In addition, availability of alternative options of treatment for neurological disorders and side effects and risks associated with neurostimulation therapy are also some of the factors hindering the growth of the market.

Geographically, North America is the largest neurostimulation device market as the region has increasing prevalence of chronic diseases and growing geriatric population. For instance, according to Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes. In addition according to National Institutes of Health, in the U.S. approximately one million people have Parkinson’s disease. As per the Alzheimer's Association in 2017, 5.5 million Americans had Alzheimer and about 5.3 million of this patient population’s age was 65 years or more. In addition, according to Alzheimer's Association approximately 14 million people are expected to suffer from Alzheimer in 2050.


Asia-Pacific is observed to witness the fastest growth in the market. Largest population, increasing prevalence of diabetes, growing geriatric population and rising adoption of neurostimulation devices is creating a positive impact on the neurostimulation device market growth in the region.   
Key players in the neurostimulation device industry are investing in the development of innovative and advance neurostimulation device products, which is strengthening their position in the market.  In September 2017, Medtronic, Inc. received FDA approval and launched the Intellis platform for the management of certain types of chronic intractable pain. Medtronic, Inc., Boston Scientific Corporation, Cyberonics, Inc., Nevro Corporation, Neurosigma, Inc., Neuropace, Inc., Biocontrol Medical, Synapse Biomedical, Inc., Neuronetics, Inc. are some of the key players offering neurostimulation devices.

Contact
VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America

Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook

Global Prefilled Syringes Market – Analysis and Forecast (2018-2024)


Prefilled syringe is a single use syringe filled with parenteral drug. It helps to exclude various numbers of procedures mandatory for administering a formulation. The global prefilled syringes market is growing at significant rate, due to mounting demand for biologics and biosimilars and emergent injectable drugs pipeline. Different types of syringes contributed to the market size. The market has witnessed high demand for conventional syringes over the last few years due to increasing adoption of self-administered injectable drug.


There are two materials of syringes, glass and plastic. Glass material is preferred for manufacturing syringe as the material is non-reactive, and have high mechanical strength, and tolerability towards heat and transparency. However, the raised leachability from silicon layer in the presence of biologics is also transferring the usage of glass to plastic. Of both, plastic prefilled syringes market witnessed the higher growth worldwide, which is due to break resistance and decreased surface reactivity.

Moreover, increasing demand for vaccine, large pool of population base and benefits associated with syringes are also up surging its demand, as parentral administration is second most common mode of drug delivery. According to the World Health Organization (WHO), globally approximately 16 billion injections are administered every year in developing and transitional countries.

Drug is delivered with various methods, such as orally, infusion, and injections. Oral delivery method is the most commonly used drug delivery alternative globally, as it is cost effective and easy to use for patients. Interaction of syringe plastic with the drugs and recall of products are the key factor hindering the global market growth.


Geographically, Europe is the largest prefilled syringe market as in the region the prevalence of chronic disease is increasing. The increasing prevalence of diabetes is a major concern in Europe. According to International Diabetes Federation (IDF) in 2015, approximately 59.8 million people were suffering from diabetes in Europe. In addition, the healthcare expenditure is increasing in Europe, which has increased the accessibility and affordability of treatment among the individuals. Growing geriatric population, increasing demand for biosimilars and biologics and technological advancement of products are also up surging growth of the European prefilled syringes market.

Key players in the prefilled syringes industry are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. According to Unilife Corporation, a company involved in the development, design and production of injectable drug delivery system, approximately 2 billion prefilled syringes are used each year globally. Becton, Dickinson and Company, Weigao Group, Gerresheimer AG, SCHOTT AG, Catalent, Inc., West Pharmaceutical Services, Inc., Ompi, Vetter Pharma International GmbH, Nipro Corporation, and MedPro Inc. are the key players offering prefilled syringes.

Contact

VynZ Research USA
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook




Global Cancer/Tumor Profiling Market – Analysis and Forecast (2018-2024)

There are various types of cancer, colorectal cancer, breast cancer, melanoma cancer, lung cancer, prostate cancer, and others cancer. Mounting occurrence of breast cancer, boosting research emphasis on breast cancer and increasing alertness about breast cancer diagnosis are some of the factors responsible for the growth of the breast cancer segment. Of all the types, the breast cancer segment account foremost share in the cancer/tumor profiling market.


The cancer/tumor profiling market is subdivided by application into clinical application and research application. Research application is expected to grow at fastest rate in the market due to the outcome of therapeutic interferences & drug-induced toxicity and progressively companies are concentrating on the usage of biomarkers as biological indicators for the improvement of diseases.

The low advantage percentage of biomarkers, imprecise governing and compensation scenario, and excessive assets investment are the major challenges for the growth of cancer/tumor profiling market. Moreover, lack of skilled professionals and lack of infrastructure are also hindering the growth of the cancer/tumor profiling market.

Geographically, North America is the largest cancer/tumor profiling market as in the region the number of cancer cases is increasing. For instance, according to GLOBOCAN in the U.S. approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012. Increasing research and funding for cancer, mounting technological adoption for treatment of cancer and presence of major leading players in the region are also up surging growth of the North American cancer/tumor profiling market.


Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base and mounting occurrence of cancer. In addition, escalating number of contract research organizations (CROs), boosting requirement for improved healthcare services in developing economies and mounting emphasis of international players on emerging markets are also creating a positive impact on the cancer/tumor profiling market growth in the region.

In April 2018, Bristol-Myers Squibb Company collaborated with Illumina, Inc. to employ Illumina’s next-generation sequencing technology in Bristol-Myers Squibb’s oncology portfolio for development and commercialize in-vitro diagnostic assays. Illumina, Inc., Genomic Health Inc., Qiagen N.V., Oxford Gene Technology, Caris Life Sciences, Neogenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Helomics Corporation, Nanostring Technologies, Inc. and Ribomed Biotechnologies, Inc. are the key players offering cancer/tumor profiling.

Contact
VynZ Research USA
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook


Sunday, 29 July 2018

North America Is the Largest Heart Pump Device Market as In the Region

Heart pump device, a battery operated mechanical heart pump device, is implanted surgically to support the function of heart ventricles. It aids to preserve the pumping capability of a heart which cannot work effectively on its own. The global heart pump device market is growing at significant rate, due to mounting occurrence of cardiovascular diseases. Different types of heart pumps contributed to the heart pump device market size. The market has witnessed high demand for implantable heart pump over the last few years due to technological advancement of devices and mounting occurrence of heart failure.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/heart-pump-device-market

On the basis of product, the heart pump market is subdivided into intra-aortic balloon pumps, ventricular assist devices and total artificial heart. Of all products, ventricular assist device market account the largest share and is also expected to grow at the fastest rate during the forecast period in the heart pump market, globally, due to technological improvements to advance the safety of these devices, mounting occurrence of heart failure and enhanced dependence on ventricular assistance devices for the management of heart failure. The ventricular assist devices are further divided into left ventricular assist devices, percutaneous ventricular assist devices, bi-ventricular assist devices, and right ventricular assist devices.

Geographically, North America is the largest heart pump device market as in the region the occurrence of cardiovascular diseases is increasing. For instance, according to the CDC, in the U.S. approximately 610,000 people die every year due to heart disease. Mounting number of regulatory approvals, expanding geriatric population, and promising reimbursement situation are also up surging growth of the North American heart pump device market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.


Asia-Pacific is observed to witness fastest growth in the market, as in the region mounting occurrence of cardiovascular diseases is mounting. In addition, boosting healthcare expenditure, mounting medical tourism, expanding geriatric population, and refining healthcare infrastructure are also creating a positive impact on the heart pump device industry growth in the region.

Key players in the heart pump device market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe.  In July 2018, Medtronic Plc received FDA approval for less invasive heart pump implant procedure. It is a HVAD System, for a left ventricular assist device (LVAD) which helps patients with advanced heart failure.
In addition, in September 2017, Medtronic Plc received approval for HeartWare HVAD System as a destination therapy for patients with progressive heart failure. Abbott Laboratories, Reliantheart, Terumo, Abiomed, Medtronic Plc, Teleflex, Getinge, Jarvik Heart, Syncardia Systems and Berlin Heart, are the key players offering heart pump devices.

About VynZ Research:

VynZ Research is a global market intelligence company providing research reports, industry intelligence and business advisory services to companies and institutions across the globe. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as chemical and materials, automotive and transportation, energy and power, consumer goods, healthcare, ICT and other emerging technologies.

Contact

VynZ Research 
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook

North America Is the Largest Surgical Navigation Market as In the Region


Surgical navigation utilizes computer software and tools to carry out surgical procedures less invasively and safely. The global surgical navigation market is growing at significant rate, due to mounting occurrence of neurological and orthopedic disorders and expanding geriatric population. Different applications contributed to the surgical navigation market size. The market has witnessed high demand for optical navigation system over the last few years due to budding alertness regarding the benefits of optical systems and decreasing radiation exposure.


Explore Full Report Description at: https://www.vynzresearch.com/healthcare/surgical-navigation-market

On the basis of patient care setting, the market is segmented into ambulatory settings and physician practice and hospitals. The larger number of patients enduring treatments in hospitals, and execution of government initiatives for fitting surgical navigation systems in hospitals are the factors growing the demand for these solutions in hospitals. Among the all patient care settings, the hospital accounted the largest share in the surgical navigation market. In addition, ambulatory settings and physician practice is expected to exhibit the fastest growth rate due to mounting recognition of systems in ambulatory settings and growing patient inclination towards clinics.

Geographically, North America is the largest surgical navigation market as in the region the acceptance of minimally invasive surgery is increasing. Mounting occurrence of ENT disorder, government support for the progress of these systems, mounting acceptance by ambulatory settings, expanding geriatric population, and escalating regulatory sanctions are also up surging growth of the North American surgical navigation industry. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/surgical-navigation-market/request-sample

Asia-Pacific is observed to witness the fastest growth in the market, as the region comprises of large population base. In addition, mounting occurrence of orthopedic disorder, boosting medical tourism, refining healthcare infrastructure, mounting healthcare expenditure and expanding geriatric population are also creating a positive impact on the surgical navigation industry growth in the region.

Medtronic PLC, Amplitude Surgical, Brainlab AG, Zimmer Biomet Holdings, Fiagon GmbH, Scopis GmbH, Karl Storz GmbH & Co. Kg, B. Braun Melsungen AG, Stryker Corporation, Inc., and Siemens AG are the key players offering surgical navigation solutions.

About VynZ Research:

VynZ Research is a global market intelligence company providing research reports, industry intelligence and business advisory services to companies and institutions across the globe. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as chemical and materials, automotive and transportation, energy and power, consumer goods, healthcare, ICT and other emerging technologies.

Contact Us:

VynZ Research
165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Website: https://www.vynzresearch.com
Email: support@vynzresearch.com
Connect With us: Linkedin | Twitter |Google | Facebook